NasdaqGS:AZTALife Sciences
Is Azenta (AZTA) Recasting Multiomics Leadership To Sharpen Its Long-Range Platform Strategy?
Azenta, Inc. recently appointed Trey Martin as President of its Multiomics business, effective April 6, 2026, succeeding Ginger Zhou, who will remain in an advisory role through November 2026 to support a smooth leadership transition.
By bringing in Martin’s extensive multi-segment life sciences leadership experience from Maravai Life Sciences, Danaher, and Integrated DNA Technologies, Azenta is explicitly tying its Multiomics leadership to its long-range plan focused on scaling global...